Designing and interpreting HIV noninferiority trials in naive and experienced patients
Baseline serum low-density lipoprotein cholesterol levels predict response to hepatitis C virus therapy in HIV/hepatitis C virus coinfected patients
High incidence of adverse events in healthy volunteers receiving rifampicin and adjusted doses of lopinavir/ritonavir tablets
Persistent Kaposi sarcoma in the era of highly active antiretroviral therapy: characterizing the predictors of clinical response
The anti-HIV activity of entecavir: a multicentre evaluation of lamivudine-experienced and lamivudine-naive patients
Treatment response in acute/early infection versus advanced AIDS: equivalent first and second phases of HIV RNA decline
Impact of HIV on novel therapies for tuberculosis control
Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000–2006
Acceptability of male circumcision among mothers with male children in Mysore, India
Is there a role for etravirine in patients with Nonnucleoside reverse transcriptase inhibitor resistance?
Suppression of HIV-1 plasma viral load below detection preserves IL-17 producing T cells in HIV-1 infection
Determination of a major histocompatibility complex class I restricting simian immunodeficiency virus Gag241–249 epitope
Does tenofovir increase efavirenz hepatotoxicity?
Methodological issues of non-inferiority trials in HIV-infected patients: a need for consensus?
Incidence of pancreatitis in HIV-infected patients, and the association with antiretroviral therapy
Immune reconstitution syndrome to Strongyloides stercoralis infection